United Therapeutics Corporation - Common Stock (NQ:UTHR)

532.78 -12.22 (-2.24%)

Delayed Quote Updated: 4:00 PM EDT, Oct 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about United Therapeutics Corporation - Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Krystal Biotech Stock Sees RS Rating Jump To 91 ↗

June 11, 2024

On Tuesday, Krystal Biotech stock cleared a key technical benchmark, seeing its Relative Strength Rating jump to 91 from 88.

Via Investor's Business Daily

10 Health Care Stocks With Whale Alerts In Today's Session ↗

June 11, 2024

Via Benzinga

Halozyme Therapeutics Scores RS Rating Jump To 91 ↗

June 07, 2024

On Friday, Halozyme Therapeutics stock earned an upgrade to its Relative Strength (RS) Rating, from 80 to 91.

Via Investor's Business Daily

For those who appreciate value investing, NASDAQ:UTHR is a compelling option with its solid fundamentals. ↗

June 05, 2024

Investors should take notice ofUNITED THERAPEUTICS CORP (NASDAQ:UTHR)—it offers a great deal for the fundamentals it presents.

Via Chartmill

United Therapeutics Corporation to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

June 05, 2024

From United Therapeutics Corporation

Via Business Wire

Expert Ratings For United Therapeutics ↗

May 21, 2024

Via Benzinga

The Latest Analyst Ratings For United Therapeutics ↗

May 02, 2024

Via Benzinga

The 3 Most Undervalued Healthcare Stocks to Buy in June 2024 ↗

June 04, 2024

Seeking discounts in relevant places makes sense and there are few arenas more compelling than undervalued healthcare stocks.

Via InvestorPlace

Liquidia Stock Surges After Winning Patent Battle Vs. United Therapeutics ↗

June 03, 2024

Liquidia stock retook its 50-day line Monday on a U.S. judge's ruling on a patent dispute with fellow biotech company United Therapeutics.

Via Investor's Business Daily

Topics Intellectual Property

7 Biotech Stocks That Could Breathe New Life Into Your Portfolio ↗

May 20, 2024

Thanks to the underlying pertinence, these established biotech stocks to buy offer confidence to investors facing tricky market conditions.

Via InvestorPlace

Halozyme Therapeutics Stock Earns IBD Stock Rating Upgrade, Hitting 80-Plus RS Rating ↗

May 16, 2024

On Thursday, biotech Halozyme Therapeutics stock had its Relative Strength (RS) Rating upgraded to 84, up from 80 a day earlier.

Via Investor's Business Daily

NASDAQ:UTHR is a prime example of a stock that offers more than what meets the eye in terms of fundamentals. ↗

May 15, 2024

UNITED THERAPEUTICS CORP (NASDAQ:UTHR), an undervalued stock with good fundamentals.

Via Chartmill

Catalyst Pharmaceuticals Stock Clears Technical Benchmark With 83 RS Rating ↗

May 14, 2024

On Tuesday, Catalyst Pharmaceuticals stock hit a key technical milestone, with its Relative Strength Rating climbing to 83 from 79.

Via Investor's Business Daily

3 Biotech Stocks to Double Your Money in the Next 24 Months ↗

May 06, 2024

The biotech sector offers significant potential for growth. These 3 biotech stocks to double your money are noteworthy candidates.

Via InvestorPlace

Lung Disease-Focused United Therapeutics Says It Is A Compelling Investment Opportunity ↗

May 01, 2024

United Therapeutics impresses with record-breaking Q1 results. Revenue soars 34% Y/Y to $677.7 million, EPS jumps to $6.17. Tyvaso leads the charge with a 56% revenue surge.

Via Benzinga

UTHR Stock Earnings: United Therapeutics Beats EPS, Beats Revenue for Q1 2024 ↗

May 01, 2024

UTHR stock results show that United Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Powell Industries Posts Upbeat Results, Joins A10 Networks, Garmin, DuPont And Other Big Stocks Moving Higher On Wednesday ↗

May 01, 2024

Via Benzinga

United Therapeutics Corporation Reports First Quarter 2024 Financial Results

May 01, 2024

From United Therapeutics Corporation

Via Business Wire

CORRECTING and REPLACING PHOTO United Therapeutics Announces World’s First Successful Xenothymokidney Transplant

April 26, 2024

From United Therapeutics Corporation

Via Business Wire

United Therapeutics Corporation to Report First Quarter 2024 Financial Results Before the Market Opens on Wednesday, May 1, 2024

April 24, 2024

From United Therapeutics Corporation

Via Business Wire

NASDAQ:UTHR stands out as a stock that provides good value for the fundamentals it showcases. ↗

April 24, 2024

Despite its impressive fundamentals, UNITED THERAPEUTICS CORP (NASDAQ:UTHR) remains undervalued.

Via Chartmill

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference

April 16, 2024

From United Therapeutics Corporation

Via Business Wire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

March 26, 2024

Via Benzinga

United Therapeutics Announces the First Comprehensive Review Publication on Xenotransplantation

March 26, 2024

From United Therapeutics Corporation

Via Business Wire

The Bargain Hunter’s Portfolio: 7 Smart Stock Buys for the Shrewd Investor ↗

March 25, 2024

Although several companies have seen their valuations blossom, you can still find bargain stocks if you know where to look.

Via InvestorPlace

United Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program

March 25, 2024

From United Therapeutics Corporation

Via Business Wire

The 3 Most Undervalued Nasdaq Stocks to Buy in March 2024 ↗

March 13, 2024

Learn about these undervalued NASDAQ stocks teeming with the potential to bounce back and show great returns for investors this year.

Via InvestorPlace

Game Changers: 3 Biotech Stocks That Could Be Multibaggers in the Making ↗

March 05, 2024

These three companies represent the world of biotech stocks and offer a unique blend of high risk and potentially high reward.

Via InvestorPlace

United Therapeutics Corporation to Present at the Leerink Partners Global Biopharma Conference 2024

March 05, 2024

From United Therapeutics Corporation

Via Business Wire

United Therapeutics Corporation to Present at the TD Cowen 44th Annual Health Care Conference

February 27, 2024

From United Therapeutics Corporation

Via Business Wire

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.